Chronic lymphocytic leukemia with deletion 17p: An Indian scenario

Ajay Gogia; Ritu Gupta; Lalit Kumar; Atul Sharma; Lata Soni

doi:10.4103/sajc.sajc_287_18

South Asian Journal of Cancer, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · South Asian J Cancer 2019; 08(01): 40-51
DOI: 10.4103/sajc.sajc_287_18

Letter to the Editor

Chronic lymphocytic leukemia with deletion 17p: An Indian scenario

Autor*innen

Ajay Gogia

Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi
Ritu Gupta

Department of Lab Oncology, All India Institute of Medical Sciences, New Delhi
Lalit Kumar

Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi
Atul Sharma

Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi
Lata Soni

Department of Lab Oncology, All India Institute of Medical Sciences, New Delhi

Abstract

als PDF herunterladen

PDF (377 kb)

Referenzen

References
1 Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-6.
2 Zenz T, Gribben JG, Hallek M, Döhner H, Keating MJ, Stilgenbauer S, et al. Risk categories and refractory CLL in the era of chemoimmunotherapy. Blood 2012;119:4101-7.
3 Strati P, Keating MJ, O'Brien SM, Ferrajoli A, Burger J, Faderl S, et al. Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion. Haematologica 2014;99:1350-5.
4 Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the international workshop on chronic lymphocytic leukemia updating the national cancer institute-working group 1996 guidelines. Blood 2008;111:5446-56.
5 Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-34.
6 Rani L, Mathur N, Gogia A, Vishnubhatla S, Kumar L, Sharma A, et al. Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia. Leuk Lymphoma 2016;57:2389-400.
7 Fischer K, Cramer P, Busch R, Böttcher S, Bahlo J, Schubert J, et al. Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: A multicenter phase II trial of the German chronic lymphocytic leukemia study group. J Clin Oncol 2012;30:3209-16.
8 Gogia A, Sharma A, Raina V, Kumar L, Vishnubhatla S, Gupta R, et al. Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India. Leuk Lymphoma 2012;53:1961-5.